相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Halting the vicious cycle within the multiple myeloma ecosystem: blocking JAM-A on bone marrow endothelial cells restores angiogenic homeostasis and suppresses tumor progression
Antonio G. Solimando et al.
HAEMATOLOGICA (2021)
Tumor angiogenesis: causes, consequences, challenges and opportunities
Roberta Lugano et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2020)
RAL GTPases mediate multiple myeloma cell survival and are activated independently of oncogenic RAS
Marcel Seibold et al.
HAEMATOLOGICA (2020)
CIC Mutation as a Molecular Mechanism of Acquired Resistance to Combined BRAF-MEK Inhibition in Extramedullary Multiple Myeloma with Central Nervous System Involvement
Matteo Claudio Da Via et al.
ONCOLOGIST (2020)
An Integrated Gene Expression Landscape Profiling Approach to Identify Lung Tumor Endothelial Cell Heterogeneity and Angiogenic Candidates
Jermaine Goveia et al.
CANCER CELL (2020)
Improving cancer immunotherapy using nanomedicines: progress, opportunities and challenges
John D. Martin et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2020)
Preclinical validation of Alpha-Enolase (ENO1) as a novel immunometabolic target in multiple myeloma
Arghya Ray et al.
ONCOGENE (2020)
CCR2 inhibition reduces tumor myeloid cells and unmasks a checkpoint inhibitor effect to slow progression of resistant murine gliomas
Joseph A. Flores-Toro et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2020)
Bortezomib Treatment Modulates Autophagy in Multiple Myeloma
Giuseppe Di Lernia et al.
JOURNAL OF CLINICAL MEDICINE (2020)
miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro
Markus Krebs et al.
JOURNAL OF CLINICAL MEDICINE (2020)
HB-EGF-EGFR Signaling in Bone Marrow Endothelial Cells Mediates Angiogenesis Associated with Multiple Myeloma
Luigia Rao et al.
CANCERS (2020)
Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma
Ilaria Saltarella et al.
CELLS (2020)
Immune system and bone microenvironment: rationale for targeted cancer therapies
Gnoni Antonio et al.
Oncotarget (2020)
Immune Checkpoint Inhibitor-Related Myositis: From Biology to Bedside
Antonio G. Solimando et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
MicroRNAs-Based Nano-Strategies as New Therapeutic Approach in Multiple Myeloma to Overcome Disease Progression and Drug Resistance
Vanessa Desantis et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
Spatial heterogeneity of oxygenation and haemodynamics in breast cancer resolved in vivo by conical multispectral optoacoustic mesoscopy
Jiao Li et al.
LIGHT-SCIENCE & APPLICATIONS (2020)
Single-Cell Approaches to Profile the Response to Immune Checkpoint Inhibitors
Lara Gibellini et al.
FRONTIERS IN IMMUNOLOGY (2020)
Anti-angiogenesis and Immunotherapy: Novel Paradigms to Envision Tailored Approaches in Renal Cell-Carcinoma
Antonella Argentiero et al.
JOURNAL OF CLINICAL MEDICINE (2020)
A Comprehensive Biological and Clinical Perspective Can Drive a Patient-Tailored Approach to Multiple Myeloma: Bridging the Gaps between the Plasma Cell and the Neoplastic Niche
Antonio Giovanni Solimando et al.
JOURNAL OF ONCOLOGY (2020)
The history and advances in cancer immunotherapy: understanding the characteristics of tumor-infiltrating immune cells and their therapeutic implications
Yuanyuan Zhang et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2020)
Targeting immune checkpoints in hematological malignancies
Basit Salik et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2020)
Junctional Adhesion Molecules in Cancer: A Paradigm for the Diverse Functions of Cell-Cell Interactions in Tumor Progression
Adam Lauko et al.
CANCER RESEARCH (2020)
Combination of anti-angiogenic therapy and immune checkpoint blockade normalizes vascular-immune crosstalk to potentiate cancer immunity
Won Suk Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2020)
A decade of immune-checkpoint inhibitors in cancer therapy
Caroline Robert
NATURE COMMUNICATIONS (2020)
Right Heart Changes Impact on Clinical Phenotype of Amyloid Cardiac Involvement: A Single Centre Study
Sebastiano Cicco et al.
LIFE-BASEL (2020)
Actors on the Scene: Immune Cells in the Myeloma Niche
Patrizia Leone et al.
FRONTIERS IN ONCOLOGY (2020)
The EGFL7-ITGB3-KLF2 axis enhances survival of multiple myeloma in preclinical models
Yousef Salama et al.
BLOOD ADVANCES (2020)
Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy
Maria Georganaki et al.
ONCOIMMUNOLOGY (2020)
Single-cell RNA sequencing reveals compromised immune microenvironment in precursor stages of multiple myeloma
Oksana Zavidij et al.
NATURE CANCER (2020)
Lenvatinib plus pembrolizumab in patients with advanced endometrial cancer: an interim analysis of a multicentre, open-label, single-arm, phase 2 trial
Vicky Makker et al.
LANCET ONCOLOGY (2019)
CAFs and TGF-β Signaling Activation by Mast Cells Contribute to Resistance to Gemcitabine/Nabpaclitaxel in Pancreatic Cancer
Letizia Porcelli et al.
CANCERS (2019)
Adverse effects of immune-checkpoint inhibitors: epidemiology, management and surveillance
Filipe Martins et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2019)
Low doses of ionizing radiation activate endothelial cells and induce angiogenesis in peritumoral tissues
Filipa Gil Marques et al.
RADIOTHERAPY AND ONCOLOGY (2019)
Cell Adhesion Molecules and Their Roles and Regulation in the Immune and Tumor Microenvironment
Heidi Harjunpaa et al.
FRONTIERS IN IMMUNOLOGY (2019)
Macrophage Polarization: Different Gene Signatures in M1(LPS+) vs. Classically and M2(LPS-) vs. Alternatively Activated Macrophages
Marco Orecchioni et al.
FRONTIERS IN IMMUNOLOGY (2019)
High-Risk Multiple Myeloma: Integrated Clinical and Omics Approach Dissects the Neoplastic Clone and the Tumor Microenvironment
Antonio Giovanni Solimando et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Gene Expression Comparison between the Lymph Node-Positive and -Negative Reveals a Peculiar Immune Microenvironment Signature and a Theranostic Role for WNT Targeting in Pancreatic Ductal Adenocarcinoma: A Pilot Study
Antonella Argentiero et al.
CANCERS (2019)
Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma
J. Larkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Emerging Role of Immune Checkpoint Inhibitors in Hepatocellular Carcinoma
Vito Longo et al.
MEDICINA-LITHUANIA (2019)
Predictive and Prognostic Factors in HCC Patients Treated with Sorafenib
Oronzo Brunetti et al.
MEDICINA-LITHUANIA (2019)
Role of BRAF in Hepatocellular Carcinoma: A Rationale for Future Targeted Cancer Therapies
Antonio Gnoni et al.
MEDICINA-LITHUANIA (2019)
Insights into the Regulation of Tumor Angiogenesis by Micro-RNAs
Patrizia Leone et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Adhesion-Mediated Multiple Myeloma (MM) Disease Progression: Junctional Adhesion Molecule a Enhances Angiogenesis and Multiple Myeloma Dissemination and Predicts Poor Survival
Antonio Giovanni Solimando et al.
BLOOD (2019)
Bone marrow fibroblasts overexpress miR-27b and miR-214 in step with multiple myeloma progression, dependent on tumour cell-derived exosomes
Maria Antonia Frassanito et al.
JOURNAL OF PATHOLOGY (2019)
Approaches to treat immune hot, altered and cold tumours with combination immunotherapies
Jerome Galon et al.
NATURE REVIEWS DRUG DISCOVERY (2019)
Quantifying Leukocyte Egress via Lymphatic Vessels from Murine Skin and Tumors
Maria M. Steele et al.
JOVE-JOURNAL OF VISUALIZED EXPERIMENTS (2019)
Bone marrow endothelial cells sustain a tumor-specific CD8+ T cell subset with suppressive function in myeloma patients
Patrizia Leone et al.
ONCOIMMUNOLOGY (2019)
Exploiting Current Understanding of Hypoxia Mediated Tumour Progression for Nanotherapeutic Development
Jie Feng et al.
CANCERS (2019)
Bone metastasis as primary presentation of pancreatic ductal adenocarcinoma: A case report and literature review
Antonella Argentiero et al.
CLINICAL CASE REPORTS (2019)
Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment
Martina Rudelius et al.
HAEMATOLOGICA (2018)
JAM-A as a prognostic factor and new therapeutic target in multiple myeloma
A. G. Solimando et al.
LEUKEMIA (2018)
Inhibition of focal adhesion kinase overcomes resistance of mantle cell lymphoma to ibrutinib in the bone marrow microenvironment
Martina Rudelius et al.
HAEMATOLOGICA (2018)
Rhu-Epo down-regulates pro-tumorigenic activity of cancer-associated fibroblasts in multiple myeloma
Vanessa Desantis et al.
ANNALS OF HEMATOLOGY (2018)
Subcutaneous immunoglobulins in patients with multiple myeloma and secondary hypogammaglobulinemia: a randomized trial
Angelo Vacca et al.
CLINICAL IMMUNOLOGY (2018)
Emerging Roles of Vascular Cell Adhesion Molecule-1 (VCAM-1) in Immunological Disorders and Cancer
Deok-Hoon Kong et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)
Increased vessel perfusion predicts the efficacy of immune checkpoint blockade
Xichen Zheng et al.
JOURNAL OF CLINICAL INVESTIGATION (2018)
Phenotype molding of stromal cells in the lung tumor microenvironment
Diether Lambrechts et al.
NATURE MEDICINE (2018)
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
Dal Fukurnura et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Improving immunotherapy outcomes with anti-angiogenic treatments and vice versa
Kabir A. Khan et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
Nivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma
R. J. Motzer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The dark side of tumor-associated endothelial cells
Francesco De Sanctis et al.
SEMINARS IN IMMUNOLOGY (2018)
Defining the role of the tumor vasculature in antitumor immunity and immunotherapy
Marco B. Schaaf et al.
CELL DEATH & DISEASE (2018)
Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors
Thomas Duhen et al.
NATURE COMMUNICATIONS (2018)
Inhibition of mTOR complex 2 restrains tumor angiogenesis in multiple myeloma
Aurelia Lamanuzzi et al.
Oncotarget (2018)
Targeting angiogenesis in multiple myeloma by the VEGF and HGF blocking DARPin® protein MP0250: a preclinical study
Luigia Rao et al.
Oncotarget (2018)
Overexpression of adhesion molecules and barrier molecules is associated with differential infiltration of immune cells in non-small cell lung cancer
Young Kwang Chae et al.
SCIENTIFIC REPORTS (2018)
Current Challenges of Cancer Anti-angiogenic Therapy and the Promise of Nanotherapeutics
Ahmed M. E. Abdalla et al.
THERANOSTICS (2018)
Contribution to Tumor Angiogenesis From Innate Immune Cells Within the Tumor Microenvironment: Implications for Immunotherapy
Adriana Albini et al.
FRONTIERS IN IMMUNOLOGY (2018)
Unraveling the Role of Angiogenesis in Cancer Ecosystems
Iratxe Zuazo-Gaztelu et al.
FRONTIERS IN ONCOLOGY (2018)
Unleashing endogenous TNF-alpha as a cancer immunotherapeutic
Steven F. Josephs et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
A multiple myeloma that progressed as type I cryoglobulinemia with skin ulcers and foot necrosis A case report
Antonio G. Solimando et al.
MEDICINE (2018)
Overcoming tumor hypoxia as a barrier to radiotherapy, chemotherapy and immunotherapy in cancer treatment
Kaitlin Graham et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Vascular Targeting to Increase the Efficiency of Immune Checkpoint Blockade in Cancer
Maria Georganaki et al.
FRONTIERS IN IMMUNOLOGY (2018)
Improving immune-vascular crosstalk for cancer immunotherapy
Yuhui Huang et al.
NATURE REVIEWS IMMUNOLOGY (2018)
Suspected Pericardial Tuberculosis Revealed as an Amyloid Pericardial Mass
Sebastiano Cicco et al.
CASE REPORTS IN HEMATOLOGY (2018)
Ly6Clo monocytes drive immunosuppression and confer resistance to anti-VEGFR2 cancer therapy
Keehoon Jung et al.
JOURNAL OF CLINICAL INVESTIGATION (2017)
Mutual regulation of tumour vessel normalization and immunostimulatory reprogramming
Lin Tian et al.
NATURE (2017)
Monitoring immune-checkpoint blockade: response evaluation and biomarker development
Mizuki Nishino et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
In vivo photolabeling of tumor-infiltrating cells reveals highly regulated egress of T-cell subsets from tumors
Tommaso Torcellan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
The small subunit of Hemilipin2, a new heterodimeric phospholipase A2 from Hemiscorpius lepturus scorpion venom, mediates the antiangiogenic effect of the whole protein
Imen Jridi et al.
TOXICON (2017)
Pre-metastatic cancer exosomes induce immune surveillance by patrolling monocytes at the metastatic niche
Michael P. Plebanek et al.
NATURE COMMUNICATIONS (2017)
Ral signaling pathway in health and cancer
Adel Rezaei Moghadam et al.
CANCER MEDICINE (2017)
Next-generation in vivo optical imaging with short-wave infrared quantum dots
Oliver T. Bruns et al.
NATURE BIOMEDICAL ENGINEERING (2017)
An HIF-1α/VEGF-A Axis in Cytotoxic T Cells Regulates Tumor Progression
Asis Palazon et al.
CANCER CELL (2017)
Challenges and Opportunities in Adapting Clinical Trial Design for Immunotherapies
Lillian L. Siu et al.
CLINICAL CANCER RESEARCH (2017)
HIF-1 at the crossroads of hypoxia, inflammation, and cancer
Kuppusamy Balamurugan
INTERNATIONAL JOURNAL OF CANCER (2016)
CCL2 Produced by the Glioma Microenvironment Is Essential for the Recruitment of Regulatory T Cells and Myeloid-Derived Suppressor Cells
Alan L. Chang et al.
CANCER RESEARCH (2016)
Targeting regulatory T cells in tumors
Chang Liu et al.
FEBS JOURNAL (2016)
Lymphatic vessels regulate immune microenvironments in human and murine melanoma
Amanda W. Lund et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
Targeting vasculogenesis to prevent progression in multiple myeloma
M. Moschetta et al.
LEUKEMIA (2016)
Targeting B-cell non Hodgkin lymphoma: New and old tricks
Antonio Giovanni Solimandoa et al.
LEUKEMIA RESEARCH (2016)
Targeting soluble CD146 with a neutralizing antibody inhibits vascularization, growth and survival of CD146-positive tumors
J. Stalin et al.
ONCOGENE (2016)
Tumor cell vascular mimicry: Novel targeting opportunity in melanoma
Mary J. C. Hendrix et al.
PHARMACOLOGY & THERAPEUTICS (2016)
Dual inhibition of Ang-2 and VEGF receptors normalizes tumor vasculature and prolongs survival in glioblastoma by altering macrophages
Teresa E. Peterson et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
High expression levels of egfl7 correlate with low endothelial cell activation in peritumoral vessels of human breast cancer
Diane Pannier et al.
ONCOLOGY LETTERS (2016)
Intraoperative intravital microscopy permits the study of human tumour vessels
Daniel T. Fisher et al.
NATURE COMMUNICATIONS (2016)
Microenvironment drug resistance in multiple myeloma: emerging new players
Lucia Di Marzo et al.
ONCOTARGET (2016)
Reengineering the Tumor Microenvironment to Alleviate Hypoxia and Overcome Cancer Heterogeneity
John D. Martin et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2016)
Hypoxia and metabolic adaptation of cancer cells
K. L. Eales et al.
ONCOGENESIS (2016)
The Role of the Tumor vasculature in the Host immune Response: implications for Therapeutic Strategies Targeting the Tumor Microenvironment
Shona A. Hendry et al.
FRONTIERS IN IMMUNOLOGY (2016)
T Cell Trafficking through Lymphatic Vessels
Morgan C. Hunter et al.
FRONTIERS IN IMMUNOLOGY (2016)
Tumour endothelial cells in high metastatic tumours promote metastasis via epigenetic dysregulation of biglycan
Nako Maishi et al.
SCIENTIFIC REPORTS (2016)
dendextend: an R package for visualizing, adjusting and comparing trees of hierarchical clustering
Tal Galili
BIOINFORMATICS (2015)
Targeting the tumor vasculature to enhance T cell activity
Evripidis Lanitis et al.
CURRENT OPINION IN IMMUNOLOGY (2015)
VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-κB-induced endothelial activation
Hua Huang et al.
FASEB JOURNAL (2015)
limma powers differential expression analyses for RNA-sequencing and microarray studies
Matthew E. Ritchie et al.
NUCLEIC ACIDS RESEARCH (2015)
Role of vascular density and normalization in response to neoadjuvant bevacizumab and chemotherapy in breast cancer patients
Sara M. Tolaney et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
T cell exclusion, immune privilege, and the tumor microenvironment
Johanna A. Joyce et al.
SCIENCE (2015)
Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus
Kevin R. Kelly et al.
ONCOTARGET (2015)
Role of endothelial progenitor cells in cancer progression
Michele Moschetta et al.
BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER (2014)
Antiangiogenesis Strategies Revisited: From Starving Tumors to Alleviating Hypoxia
Rakesh K. Jain
CANCER CELL (2014)
Cell adhesion molecules and their relation to (cancer) cell stemness
Ensieh Farahani et al.
CARCINOGENESIS (2014)
A HGF/cMET Autocrine Loop Is Operative in Multiple Myeloma Bone Marrow Endothelial Cells and May Represent a Novel Therapeutic Target
Arianna Ferrucci et al.
CLINICAL CANCER RESEARCH (2014)
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma
S. Vincent Rajkumar et al.
LANCET ONCOLOGY (2014)
Functional polarization of tumour-associated macrophages by tumour-derived lactic acid
Oscar R. Colegio et al.
NATURE (2014)
Integrin α9 on lymphatic endothelial cells regulates lymphocyte egress
Koyu Ito et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Antiangiogenic Therapies: Going beyond Their Limits
Lidia Moserle et al.
CANCER DISCOVERY (2014)
Location, location, location: functional and phenotypic heterogeneity between tumor-infiltrating and non-infiltrating myeloid-derived suppressor cells
Sarah K. Maenhout et al.
ONCOIMMUNOLOGY (2014)
Hypoxia and the extracellular matrix: drivers of tumour metastasis
Daniele M. Gilkes et al.
NATURE REVIEWS CANCER (2014)
Endothelial endoglin is involved in inflammation: role in leukocyte adhesion and transmigration
Elisa Rossi et al.
BLOOD (2013)
Hypoxia induces epithelial-mesenchymal transition via activation of SNAI1 by hypoxia-inducible factor-1α in hepatocellular carcinoma
Lin Zhang et al.
BMC CANCER (2013)
Expression of cell adhesion molecules and prognosis in breast cancer
S. Saadatmand et al.
BRITISH JOURNAL OF SURGERY (2013)
Vascular Normalization as an Emerging Strategy to Enhance Cancer Immunotherapy
Yuhui Huang et al.
CANCER RESEARCH (2013)
Angiopoietin-2: An Attractive Target for Improved Antiangiogenic Tumor Therapy
Damien Gerald et al.
CANCER RESEARCH (2013)
Novel Targeting of Phospho-cMET Overcomes Drug Resistance and Induces Antitumor Activity in Multiple Myeloma
Michele Moschetta et al.
CLINICAL CANCER RESEARCH (2013)
Normalizing Tumor Microenvironment to Treat Cancer: Bench to Bedside to Biomarkers
Rakesh K. Jain
JOURNAL OF CLINICAL ONCOLOGY (2013)
Tetraspanin CD9 links junctional adhesion molecule-A to αvβ3 integrin to mediate basic fibroblast growth factor-specific angiogenic signaling
Swetha S. D. Peddibhotla et al.
MOLECULAR BIOLOGY OF THE CELL (2013)
Mouse models for studying angiogenesis and lymphangiogenesis in cancer
Lauri Eklund et al.
MOLECULAR ONCOLOGY (2013)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
Microenvironmental regulation of tumor progression and metastasis
Daniela F. Quail et al.
NATURE MEDICINE (2013)
Targeting Angiogenesis and the Tumor Microenvironment
Jennifer Samples et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2013)
Multiple myeloma is affected by multiple and heterogeneous somatic mutations in adhesion- and receptor tyrosine kinase signaling molecules
E. Leich et al.
BLOOD CANCER JOURNAL (2013)
From seeing to believing: labelling strategies for in vivo cell-tracking experiments
Fraenze Progatzky et al.
INTERFACE FOCUS (2013)
Role of non-classical MHC class I molecules in cancer immunosuppression
Grazyna Kochan et al.
ONCOIMMUNOLOGY (2013)
T-Regulatory Cells: Key Players in Tumor Immune Escape and Angiogenesis
Andrea Facciabene et al.
CANCER RESEARCH (2012)
Bone Marrow Microenvironment in Multiple Myeloma Progression
S. Manier et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2012)
Relation between bevacizumab dose intensity and high-grade glioma survival: a retrospective study in two large cohorts
Veronique Lorgis et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Differential drug class-specific metastatic effects following treatment with a panel of angiogenesis inhibitors
Alicia S. Chung et al.
JOURNAL OF PATHOLOGY (2012)
Vascular normalizing doses of antiangiogenic treatment reprogram the immunosuppressive tumor microenvironment and enhance immunotherapy
Yuhui Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia
Sarah J. Conley et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Induction Therapy and Stem Cell Mobilization in Patients with Newly Diagnosed Multiple Myeloma
Roberto Ria et al.
STEM CELLS INTERNATIONAL (2012)
Hypoxia promotes tumor growth in linking angiogenesis to immune escape
Salem Chouaib et al.
FRONTIERS IN IMMUNOLOGY (2012)
HRG Inhibits Tumor Growth and Metastasis by Inducing Macrophage Polarization and Vessel Normalization through Downregulation of PIGF
Charlotte Rolny et al.
CANCER CELL (2011)
Egfl7 Promotes Tumor Escape from Immunity by Repressing Endothelial Cell Activation
Suzanne Delfortrie et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
Targeting the interplay between myeloma cells and the bone marrow microenvironment in myeloma
Masahiro Abe
INTERNATIONAL JOURNAL OF HEMATOLOGY (2011)
NORMALIZATION OF THE VASCULATURE FOR TREATMENT OF CANCER AND OTHER DISEASES
Shom Goel et al.
PHYSIOLOGICAL REVIEWS (2011)
HLA-E expression by gynecological cancers restrains tumor-infiltrating CD8+ T lymphocytes
Marloes Gooden et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Extracellular Matrix Degradation and Remodeling in Development and Disease
Pengfei Lu et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2011)
Targeting hypoxia in cancer therapy
William R. Wilson et al.
NATURE REVIEWS CANCER (2011)
The Immune Microenvironment of Myeloma
Kimberly Noonan et al.
CANCER MICROENVIRONMENT (2011)
Effects of Acute versus Chronic Hypoxia on DNA Damage Responses and Genomic Instability
Isabel M. Pires et al.
CANCER RESEARCH (2010)
Angiopoietin-2 Interferes with Anti-VEGFR2-Induced Vessel Normalization and Survival Benefit in Mice Bearing Gliomas
Sung-Suk Chae et al.
CLINICAL CANCER RESEARCH (2010)
Chemokines and chemokine receptors: new insights into cancer-related inflammation
Gwendal Lazennec et al.
TRENDS IN MOLECULAR MEDICINE (2010)
In Vivo Imaging in Cancer
John Condeelis et al.
COLD SPRING HARBOR PERSPECTIVES IN BIOLOGY (2010)
The hypoxic microenvironment maintains glioblastoma stem cells and promotes reprogramming towards a cancer stem cell phenotype
John M. Heddleston et al.
CELL CYCLE (2009)
Infections in Patients with Multiple Myeloma in the Era of High-Dose Therapy and Novel Agents
Marcio Nucci et al.
CLINICAL INFECTIOUS DISEASES (2009)
Hypoxia and Radiation Therapy: Past History, Ongoing Research, and Future Promise
Sara Rockwell et al.
CURRENT MOLECULAR MEDICINE (2009)
Three-dimensional microscopy of the tumor microenvironment in vivo using optical frequency domain imaging
Benjamin J. Vakoc et al.
NATURE MEDICINE (2009)
The angiogenic switch in carcinogenesis
Vanessa Baeriswyl et al.
SEMINARS IN CANCER BIOLOGY (2009)
The roles of cell adhesion molecules in tumor suppression and cell migration A new paradox
Mei Chung Moh et al.
CELL ADHESION & MIGRATION (2009)
Hypoxia induces autophagic cell death in apoptosis-competent cells through a mechanism involving BNIP3
Meghan B. Azad et al.
AUTOPHAGY (2008)
Antiangiogenesis in haematological malignancies
William W. Li et al.
BRITISH JOURNAL OF HAEMATOLOGY (2008)
IFN-γ- and TNF-dependent bystander eradication of antigen-loss variants in established mouse cancers
Bin Zhang et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Vascular normalization in Rgs5-deficient tumours promotes immune destruction
Juliana Hamzah et al.
NATURE (2008)
Molecular origins of cancer: Tumor angiogenesis
Robert S. Kerbel
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Monitoring cellular movement in vivo with photoconvertible fluorescence protein Kaede transgenic mice
Michio Tomura et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Endothelial progenitor cells control the angiogenic switch in mouse lung metastasis
Dingcheng Gao et al.
SCIENCE (2008)
Finding a way out: lymphocyte egress from lymphoid organs
Susan R. Schwab et al.
NATURE IMMUNOLOGY (2007)
Hypoxia and cancer
M. Christiane Brahimi-Horn et al.
JOURNAL OF MOLECULAR MEDICINE-JMM (2007)
Targeting selectins and selectin ligands in inflammation and cancer
Steven R. Barthel et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2007)
Human effector memory CD4+ T cells directly recognize allogeneic endothelial cells in vitro and in vivo
Stephen L. Shiao et al.
JOURNAL OF IMMUNOLOGY (2007)
The structure of the vascular network of tumors
Domenico Ribatti et al.
CANCER LETTERS (2007)
Effects of vascular endothelial growth factor on the lymphocyte-endothelium interactions: Identification of caveolin-1 and nitric oxide as control points of endothelial cell anergy
Caroline Bouzin et al.
JOURNAL OF IMMUNOLOGY (2007)
Dendritic cell-endothelial cell cross-talk in angiogenesis
Silvano Sozzani et al.
TRENDS IN IMMUNOLOGY (2007)
Getting to the site of inflammation: the leukocyte adhesion cascade updated
Klaus Ley et al.
NATURE REVIEWS IMMUNOLOGY (2007)
Angiogenesis-independent tumor growth mediated by stem-like cancer cells
Per O. Sakariassen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Endothelial cell anergy is mediated by bFGF through the sustained activation of p38-MAPK and NF-κB inhibition
V. Flati et al.
INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY (2006)
Translating tumor hypoxia: Unfolded protein response (UPR)-dependent and UPR-independent pathways
Constantinos Koumenis et al.
MOLECULAR CANCER RESEARCH (2006)
Circulating endothelial cells, endothelial progenitor cells, and endothelial microparticles in cancer
P. K. Y. Goon et al.
NEOPLASIA (2006)
A hybrid mathematical model of solid tumour invasion: the importance of cell adhesion
ARA Anderson
MATHEMATICAL MEDICINE AND BIOLOGY-A JOURNAL OF THE IMA (2005)
Active participation of endothelial cells in inflammation
JM Cook-Mills et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2005)
affy -: analysis of Affymetrix GeneChip data at the probe level
L Gautier et al.
BIOINFORMATICS (2004)
Lymphatics at the crossroads of angiogenesis and lymphangiogenesis
C Scavelli et al.
JOURNAL OF ANATOMY (2004)
Regulation of leukocyte transmigration: Cell surface interactions and signaling events
Y Liu et al.
JOURNAL OF IMMUNOLOGY (2004)
Physiological and pathological responses to hypoxia
C Michiels
AMERICAN JOURNAL OF PATHOLOGY (2004)
Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies
AM Shannon et al.
CANCER TREATMENT REVIEWS (2003)
Deficiencies of GM-CSF and interferon γ link inflammation and cancer
T Enzler et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Circulating endothelial progenitor cells, vascular function, and cardiovascular risk
JM Hill et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Intra-tumoural microvessel density in human solid tumours
J Hasan et al.
BRITISH JOURNAL OF CANCER (2002)
Abnormalities in pericytes on blood vessels and endothelial sprouts in tumors
S Morikawa et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
Activation of the nitric oxide synthase pathway represents a key component of tumor necrosis factor-related apoptosis-inducing ligand-mediated cytotoxicity on hematologic malignancies
P Secchiero et al.
BLOOD (2001)
In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy
EB Brown et al.
NATURE MEDICINE (2001)
Vascular endothelial growth factor signaling pathway as an emerging target in hematologic malignancies
AF List
ONCOLOGIST (2001)
The discovery of angiogenic factors: A historical review
D Ribatti et al.
GENERAL PHARMACOLOGY-THE VASCULAR SYSTEM (2000)
分享论文
